ArticleClinical ophthalmology (Auckland, N.Z.)2026
Collaborative Diagnostic Pathways for Unilateral Orbital Disease: A Clinicopathological Series.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unilateral Orbital Lymphomas: A Structured Multidisciplinary Workflow for Diagnosis and Management.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report a retrospective tertiary-center series of unilateral orbital lesions and to illustrate a structured, experience-based multidisciplinary workflow integrating clinical, radiologic, and histopathologic data to support differential diagnosis and management in real-world practice. Patients and Methods: This retrospective descriptive case-series included 18 patients with biopsy-confirmed unilateral orbital lesions evaluated between January 2021 and March 2025 at the Oculoplastic and Orbital Surgery Unit, Humanitas Research Hospital, Milan. Demographic, clinical, imaging, and histopathologic data were analyzed. Imaging included computed tomography (CT), magnetic resonance imaging (MRI) with diffusion-weighted imaging (DWI), and functional techniques such as MRA, PET/CT when indicated. Histopathology incorporated immunohistochemistry (IHC) and proliferative indices (Ki-67). Outcomes included final diagnosis, treatment, and early recurrence. Results: 18 patients were included: dermoid cysts (n = 3), vascular malformations (n = 6), neurofibroma (n = 1), idiopathic orbital inflammation (n = 2), meningioma (n = 1), and epithelial malignancies (adenoid cystic carcinoma, basal cell carcinoma, squamous cell carcinoma, mucinous carcinoma, Merkel cell carcinoma; n = 5). Characteristic MRI and IHC patterns enabled accurate subclassification and guided informed-individualized management decisions, ranging from observation or image-guided sclerotherapy to complete surgical excision or multidisciplinary oncologic therapy. No recurrence occurred among benign lesions. Malignant epithelial tumors required adjuvant radiotherapy or systemic therapy according to histologic subtype and TNM stage. Conclusion: A systematic, multidisciplinary approach integrating cross-sectional imaging and histopathologic assessment underpins effective diagnostic and therapeutic decision-making in unilateral orbital disease. The proposed workflow, derived from institutional practice, offers an illustrative and reproducible framework for clinical reasoning and therapeutic decision-making based on real case scenarios. Its adaptability lies in the use of structured clinical-radiologic algorithms, which may help optimize individualized management, facilitate timely referral, and reduce unnecessary invasive procedures, particularly within tertiary referral settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.